QPS, LLC
Form 483 issued January 30, 2026 · Newark, Delaware
- Inspection
- Jan 27 – Jan 30, 2026
- Investigator
- Sylvestre K. Dossou
- Observations
- 2
- Pages
- 2
- FEI number
- 3003581184
In short: On January 30, 2026, FDA issued a Form 483 with 2 observations to QPS, LLC in Newark, Delaware (FEI 3003581184) after an inspection that ran Jan 27 – Jan 30, 2026. The investigator was Sylvestre K. Dossou. Most observations concern clinical (BIMO).
At a glance
2 of 2 observations on this 483 concern clinical (bimo).
What FDA observed
Preview: the opening words of each observation- 01
The firm did not…
- 02
The firm had source records with discrepant documentations that did not allow complete reconstruction of freeze…
This inspection in context
Sylvestre K. Dossou
2 documents · 2025–2026
Cites 320.29 (analytical methods for an in vivo bioavailability or bioequivalence study) more than any other section. Most of their documents are for sites in Delaware.
The firmQPS, LLC history
The site's inspection history, in date order.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at QPS, LLC?
FDA listed 2 observations on this Form 483, mostly about clinical (BIMO). The opening words of each observation are shown on this page.
Who inspected QPS, LLC?
Sylvestre K. Dossou is named on this Form 483, for the inspection of Jan 27 – Jan 30, 2026. Each investigator has a profile showing what they cite most.
When was QPS, LLC inspected by FDA?
The inspection ran Jan 27 – Jan 30, 2026, and the Form 483 is dated January 30, 2026.
How do I get the full Form 483 for QPS, LLC?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.